Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TIFFANY ALI

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1083090294
CMS profile
10913586
Location
WILLIAMSVILLE, NY

General Payments · PY2021–2024

$1,212.30

  • Reported across 23 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$680.73

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $680.73 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $124.99 1
PY2022 $261.26 3
PY2023 $145.32 2
PY2024 $680.73 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $124.56 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105554610 CMS
AstraZeneca Pharmaceuticals LP $40.01 05/06/2024 Food and Beverage Undisputed 01/23/2026 1104497762 CMS
AstraZeneca Pharmaceuticals LP $124.56 08/21/2024 Food and Beverage Undisputed 01/23/2026 1104779114 CMS
AstraZeneca Pharmaceuticals LP $14.51 10/16/2024 Food and Beverage Undisputed 01/23/2026 1104706741 CMS
AstraZeneca Pharmaceuticals LP $15.13 11/05/2024 Food and Beverage Undisputed 01/23/2026 1104378131 CMS
AstraZeneca Pharmaceuticals LP $14.12 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105445424 CMS
AstraZeneca Pharmaceuticals LP $15.13 12/05/2024 Food and Beverage Undisputed 01/23/2026 1104609414 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.88 08/18/2024 Food and Beverage Undisputed 01/23/2026 1086298084 CMS
Boston Scientific Corporation $137.96 09/25/2024 Food and Beverage Undisputed 01/23/2026 1092301551 CMS
Esperion Therapeutics, Inc. $22.33 05/07/2024 Food and Beverage Undisputed 01/23/2026 1129461392 CMS
Exact Sciences Corporation $19.36 12/16/2024 Food and Beverage Undisputed 01/23/2026 1114573691 CMS
Merck Sharp & Dohme LLC $28.61 09/23/2024 Food and Beverage Undisputed 01/23/2026 1141825277 CMS
Novartis Pharmaceuticals Corporation $23.41 10/07/2024 Food and Beverage Undisputed 01/23/2026 1086777257 CMS
Novo Nordisk Inc $16.09 08/13/2024 Food and Beverage Undisputed 01/23/2026 1100358312 CMS
Novo Nordisk Inc $18.67 10/01/2024 Food and Beverage Undisputed 01/23/2026 1100394574 CMS
Novo Nordisk Inc $20.61 11/12/2024 Food and Beverage Undisputed 01/23/2026 1100473201 CMS
Sumitomo Pharma America, Inc. $28.79 10/15/2024 Food and Beverage Undisputed 01/23/2026 1148941007 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.